Newsmeme!
Discover News you didn't know existed
Vimpat (lacosamide), a new adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older, has been launched in the UK.
MADISON, Wis.----EraGen Biosciences Inc. today announced it has appointed Inter Medico, the largest privately-owned medical diagnostics distributor in Canada, as the exclusive distributor of the company’s molecular diagnostic products in the Canadian market.
While making it easier for clinicians and patients to prepare and administer therapies, advances in drug-delivery systems for premeasured single doses also support precise dosing and hold the promise of reducing medical errors.
BioReliance Corporation announced today that Andrew "Pat" Paterson, Ph.D. has been named Senior Director/General Manager for UK Operations. Dr. Paterson will report to Dr. James Kramer, Vice President, Global Operations, Biologics of BioReliance.
ROCKVILLE, Md.----BioReliance Corporation announced today that Andrew “Pat” Paterson, Ph.D. has been named Senior Director/General Manager for UK Operations. Dr. Paterson will report to Dr.
LA JUNTA, Colo. — Church hasn’t been out but a couple hours, and there are free sandwiches in the fellowship hall for anyone interested in hearing why Colorado should become the first state where voters say life begins at conception.
http://www.amdl.com) AMDL, Inc. , a vertically integrated pharmaceutical company with major operations in China and the US, today announced it has restructured its business into three distinct divisions to better reflect the Company's operational focus on becoming a world-class, diversified pharmaceutical company.
A study published in Cancer Research, a journal of the American Association for Cancer Research, suggests a possible role for nicotine in breast tumor development and metastases. The study, conducted by researchers at the Beth Israel Deaconess Medical Center, is among the first to explore the effects of nicotine on mammary cells.
MORRIS PLAINS, N.J., Oct. 14, 2008 -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, announced that U.S. patent 7,435,803 was issued today covering the composition of matter and the use of humanized, chimeric and human anti-CD20 antibodies and antibody fusion proteins or fragments thereof comprising at ...
ATTENTION EDITORS, SYDNEY, Oct. 14/AsiaNet/ -- SYNAPTICS TECHNOLOGY...
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |